Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of D-0502 in Healthy Postmenopausal Women
NCT03810625Phase 1Completed
- Sponsor
- InventisBio
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of taragarestrant in breast cancer (2 arms), sponsored by InventisBio. Primary endpoints: Area Under the Plasma Concentration versus Time Curve, Maximum Plasma Drug Concentration and 2 more. Started Oct 2018; status: completed.
02
Drugs
taragarestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03810625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03810625.